Earways
•
1 like•1,899 views
EARWAYS MEDICAL is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, EARWAYS MEDICAL provides easy-to-use ear care products, designed for clinicians and home use.
Recommended
More Related Content
Similar to Earways
Similar to Earways (20)
Recently uploaded
Recently uploaded (20)
Earways
- 2. Leadership Team Dr. Amir KRAITZER, Founder & CEO A seasoned biomaterials specialist, entrepreneur, and inventor in the field of medical devices. Amir has a proven track record in management and problem-solving in both industrial and scientific environments. With over a decade of experience in leading biomaterials and biomedical multidisciplinary projects from the initial concept through global sales. Previously, Amir was a co- founder and CEO of Augma – a biomaterials company developing bone graft substitutes. Amir holds a Ph.D. in Biomedical engineering and an MBA from Tel-Aviv University, Israel Yael KARLIN General Manager Accomplished executive with extensive international experience in the start-up ecosystem, holding a comprehensive knowledge of the life science industry. Advising and coaching start-ups on strategy, business development, and raising capital for over a decade. Yael excels at creating partnerships and joint ventures brining companies to commercialization. Yael holds an MBA and a BA in Management from Ben Gurion University, Israel
- 3. Our mission EARWAYS MEDICAL is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, EARWAYS MEDICAL provides easy-to- use ear care products, designed for clinicians and home use.
- 4. When Cerumen (Earwax) Becomes an Impaction 1,12bn People suffer from: Recurrent Cerumen Impaction SYMPTOMS: Treatable Hearing loss - 1st reason World Wide Pain & Discomfort Dizziness & Vertigo Tinnitus Depression & Paranoia Social Isolation Learning disabilities & speech disorders Cerumen Impaction 57% Older Adults 10% Children 5% Healthy Adults 33% people with developmental disabilities
- 5. Unmet need • ENTs • 3 MONTHS AVERAGE WAITING TIME • ACCESS AND CONVINIENCE (Older adults) • PROCEDURE REQUIREMENT – (Microscope) • HEALTHCARE PROVIDORS (Non ENT) • LOW EFFICACY & SAFETY OF OTHER AVAILABLE TREATMENTS • CHAIR TIME • CROSS CONTAMINATION Healthcare Professionals NO EFFECTIVE AND SAFE PRODUCT LONG TREATMENT TIME (Ear drops) 70% OF WESTERN POPULATION USES COTTON SWABS DESPITE FDA RESTRICTIONS 60-80% OF HEARING AIDS CLOGGED BY CERUMEN Homecare Current Gold Standard: Removal By ENT Specialist
- 6. New Paradigm in the Ear Care Landscape Life Expectancy is increasing Hearing Aids market growing Increased use of Headsets and Earplugs Growing Home Care market Market Opportunity
- 7. The solution: Release with a Twist The innovative patent pending EarWayTM Pro and EarWayTM HomeCare products are designed to enable simple cerumen extraction and management of earwax accumulation and impaction
- 9. Clinical Validation 350 More than 350 successful earwax removal cases Reduces treatment time and complexity Proven safety and 87% efficacy in clinical study Clinical validation by ENTs, Audiologists GP’s & Nurses
- 10. Business Model
- 11. 3. Home Care 1. ENT’s 2. Health Care providersGet ENTs Buy-in and approval first!
- 12. Financials
- 13. EARWAYS MEDICALs Total Addressable Market EU & US* *This slide is not addressing the potential of the Asian, African and Latin American markets due to lack of accurate market data in the field $610M $4.4B $1.3B $2.7B EuropeNorth America EarWay™ Homecare EarWay™ Pro
- 14. Financing Investor Sum Pre Money Valuation $10M Tnufa $50K Self funding $50K Angel Investor $100K Parnasa VC $250K OCS (Office of the Israeli chief scientist) $350K Round A $3M Post Money Valuation $13M Use of proceeds R&D Complete Development & Manufacturing of Pro and EarWay™ HomeCare Regulatory Patents Clinical studies Business development Market Testing Marketing Sales Expansion into new territories Head counts Commence EarWay Optic Seeking $3M
- 15. Funding Angel Investor VC PARNASA Israeli OCS Matching fund Regulatory & QA Class 1, Self declared ISO 13485 CE approved FDA – April 2017 Israeli HMO IP National phase submitted 3 patents EU Israel China Japan Clinical Scientific Advisory Board Clinical Study KAPLAN MEDICAL CENTER Feasibility testing Products EarWay™ PRO transfer to mass production EarWay™ Home care advanced design stage EarWay™ Optic Distribution MOU with DACH Distributor MOU with Israeli distributor Market testing with Belgian/French Distributor MOU with UK and Ireland Distributor Negotiations with US distributor July 2017
- 16. Patient Testimonials Dr Kraitzer, I suffer from chronic cerumen imapction. I just got out of my routine ENT visit, and have been treated with WonderTip. The treatment that usually lasts over 20 minutes took a minute and a half for both ears!!! The pictures I sent tell the story of what came out of my problematic ears… Thank you very much! R.B. 43 Years Old